EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis

María José Gómara iD, Juan C Sarmiento-Monroy iD, Raul Castellanos-Moreira, José A Gómez-Puerta iD, Raimon Sanmartí, Isabel Haro iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von María José Gómara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Synthesis and Biomedical Applications of Peptides, Institut de Química Avançada de Catalunya, Consejo Superior de Investigaciones Científicas…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Phosphopyruvate Hydratase, Protein Processing, Post-Translational, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Spanish Ministry of Science, Innovation and Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the aim of improving the uncertainties associated with the correct diagnosis of seronegative rheumatoid arthritis (RA) and identifying those at risk of developing interstitial lung disease (ILD), we have designed new peptide antigens bearing three post-translational modifications (PTMs) (citrulline, homocitrulline and acetyl-lysine) related to RA that could complement existing tests based on anti-citrullinated peptide/protein antibodies (ACPAs). Several chimeric peptides were synthesized and comparatively tested as antigens in ELISAs with two cohorts of sera: 178 RAs and 110 healthy blood donors. The results indicated that although chimeric peptides containing all three PTMs and vimentin and enolase domains do not significantly outperform existing ACPA tests in terms of sensitivity and specificity, they show potential to complement current assays, especially when detecting antibodies in some seronegative patients. Furthermore, the presence of these autoantibodies significantly identified patients with RA and ILD. We can conclude that the identification of specific autoantibody profiles using synthetic antigens containing peptide domains derived from proteins present in the human joint could help in the early detection of the risk of ILD in patients with RA and be useful for adapting follow-up strategies and guiding decisions during treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidPhosphopyruvate HydrataseProtein Processing, Post-TranslationalPeptidesCitrullinationHumansFemaleMaleMiddle AgedAcetylationAutoantibodiesCitrullineAdultAgedSeverity of Illness IndexVimentinLung Diseases, Interstitial

Stichwörter der Autor:innen

acetylationchimeric peptidescitrullinationdiagnosisenolasefibrinfilaggrinhomocitrullinationinterstitial lung diseaserheumatoid arthritissynthetic peptidesvimentin

Substanzen

Phosphopyruvate HydratasePeptidesAutoantibodiesCitrullinehomocitrullineVimentin

Autor:innen und Institutionen

  • Unit of Synthesis and Biomedical Applications of Peptides, Institut de Química Avançada de Catalunya, Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.
  • Department of Rheumatology, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.

ORCID-Profile: María José Gómara, Juan C Sarmiento-Monroy, José A Gómez-Puerta, Isabel Haro

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Spanish Ministry of Science, Innovation and Universities

Zitieren

APA

Gómara, M. J., Sarmiento-Monroy, J. C., Castellanos-Moreira, R., Gómez-Puerta, J. A., Sanmartí, R., & Haro, I. (2024). Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910654

Vancouver

Gómara MJ, Sarmiento-Monroy JC, Castellanos-Moreira R, Gómez-Puerta JA, Sanmartí R, Haro I. Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910654

BibTeX
@article{Gmara2024,
  author = {Gómara, María José and Sarmiento-Monroy, Juan C and Castellanos-Moreira, Raul and Gómez-Puerta, José A and Sanmartí, Raimon and Haro, Isabel},
  title = {Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910654}
}
Kostenlos starten →